Free Review Articles on Osteoporosis                                 Metatextbook

Freie Reviews über Osteoporose                                 Look here for Journal Homepages

  • Osteoporosis
  • Teriparatide
  • Odanacatib
  • Lasofoxifene
  • Raloxifene
  • Alendronate
  • Etidronate
  • Risedronate
  • Bisphosphonates
  • Spine (Vertebroplasty)
  • Spine and spinal cord (Traumatology)
  • PCD (Multiple myeloma and other plasma cell dyscrasias)
  • Osteoblasts
  • Osteoclasts
  • Bortezomib
  • Dickkopf1
  • Bone (Metastasis)
  • Thalidomide
  • Wnt beta Catenin TCF
  • LRP5 Arrow
  • Sympathetic nervous system
  • CathepsinK
  • Strontium ranelate
  • Systemic lupus erythematosus
  • Orthopanography
  • Bariatric surgery
  • SERM
  • Glucocorticoids
  • COPD
  • Bone (Traumatology)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12006Osteoporosis and its management.



    		+-nlBMJ 333(7581):1251-6 (2006)
    22000Osteoporosis: epidemiology, diagnosis, and treatment.



    		+-nlSouth Med J 93(1):2-18 (2000)
    32009Managing osteoporosis: challenges and strategies.



    		+-nlCleve Clin J Med 76(8):457-66 (2009)
    42008Using biochemical markers of bone turnover in clinical practice.



    		+-nlCleve Clin J Med 75(10):739-50 (2008)
    52008Clinical challenges in the management of osteoporosis.



    		+-nlClin Interv Aging 3(2):315-29 (2008)
    62007Teriparatide in the management of osteoporosis.



    		+-nlClin Interv Aging 2(4):499-507 (2007)
    72001Diagnostic challenges in osteoporosis. Indications for bone densitometry and establishing secondary causes.



    		+-nlCan Fam Physician 47(-):1244-50 (2001)
    82008The diagnosis and treatment of primary osteoporosis according to current guidelines.



    		+-nlDtsch Arztebl Int 105(33):573-81; quiz 581-2 (2008)
    92010Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women.



    		+-nlJ Osteoporos 2010(-):- (2010)
    102009Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.



    		+-nlTher Clin Risk Manag 5(-):817-27 (2009)
    112007Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.



    		+-nlHealth Technol Assess 11(7):iii-iv, ix-xi, 1-231 (2007)
    122005A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.



    		+-nlHealth Technol Assess 9(22):1-160 (2005)
    132002Treatment of established osteoporosis: a systematic review and cost-utility analysis.



    		+-nlHealth Technol Assess 6(29):1-146 (2002)
    142010Lasofoxifene: Evidence of its therapeutic value in osteoporosis.



    		+-nlCore Evid 4(-):113-29 (2010)
    152010Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.



    		+-nlCore Evid 4(-):13-23 (2010)
    162009Developments in the scientific understanding of osteoporosis.



    		+-nlArthritis Res Ther 11(3):228 (2009)
    172001The management of osteoporosis.



    		+-nlJ Bone Joint Surg Br 83(3):316-23 (2001)
    182007Osteopenia and cancer in children and adolescents: the fragility of success.



    		+-nlCancer 109(7):1420-31 (2007)
    192008Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.



    		+-nlOncologist 13(2):187-95 (2008)
    202006Bone loss and fracture risk associated with cancer therapy.



    		+-nlOncologist 11(10):1121-31 (2006)
    212001Sex steroids and bone.



    		+-nlPhysiol Rev 81(1):419-447 (2001)
    222008Osteoporosis in men.



    		+-nlEndocr Rev 29(4):441-64 (2008)
    232005Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.



    		+-nlEndocr Rev 26(5):688-703 (2005)
    242005Biochemical markers of bone turnover: part I: biochemistry and variability.



    		+-nlClin Biochem Rev 26(4):97-122 (2005)
    252007An integrated approach: bisphosphonate management for the treatment of osteoporosis.



    		+-nlAm J Manag Care 13 Suppl 11(-):S290-308; quiz S309-12 (2007)
    262004Medical management of osteoporosis.



    		+-nlAm J Manag Care 10(7 Pt 1):445-55 (2004)
    272001Evaluation and treatment of postmenopausal osteoporosis.



    		+-nlAm J Manag Care 7 Spec No(-):SP5-16 (2001)
    282001Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.



    		+-nlArthritis Rheum 44(7):1496-503 (2001)
    291999The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.



    		+-nlArthritis Rheum 42(8):1740-51 (1999)
    302008Management of osteoporosis in children.



    		+-nlEur J Endocrinol 159 Suppl 1(-):S33-9 (2008)
    311997Glucocorticoid osteoporosis--mechanisms and management.



    		+-nlEur J Endocrinol 137(3):209-17 (1997)
    322000Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.



    		+-nlGut 46 Suppl 1(-):i1-8 (2000)
    332005Pathogenesis of osteoporosis: concepts, conflicts, and prospects.



    		+-nlJ Clin Invest 115(12):3318-25 (2005)
    342001Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem.



    		+-nlJ Endocrinol 168(3):353-62 (2001)
    352007Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.



    		+-nlJ Musculoskelet Neuronal Interact 7(2):174-84 (2007)
    362002Clinical use of bone densitometry: clinical applications.



    		+-nlJAMA 288(15):1898-900 (2002)
    372002Clinical use of bone densitometry: scientific review.



    		+-nlJAMA 288(15):1889-97 (2002)
    382006Diagnosis, screening, prevention, and treatment of osteoporosis.



    		+-nlMayo Clin Proc 81(5):662-72 (2006)
    392002Secondary causes of osteoporosis.



    		+-nlMayo Clin Proc 77(5):453-68 (2002)
    402002Osteoporosis.



    		+-nlPostgrad Med J 78(923):526-32 (2002)
    412002Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe.



    		+-nlPostgrad Med J 78(918):242-3 (2002)
    422002Management of corticosteroid-induced osteoporosis.



    		+-nlRheumatology (Oxford) 41(10):1088-94 (2002)
    431991Understanding osteoporosis.



    		+-nlWest J Med 155(1):53-60 (1991)
    441991Overview of osteoporosis.



    		+-nlWest J Med 154(1):63-77 (1991) Riggs BL
    452008Osteoporosis in celiac disease and in endocrine and reproductive disorders.



    		+-nlWorld J Gastroenterol 14(4):498-505 (2008)
    462007Basic and clinical aspects of osteoporosis in inflammatory bowel disease.



    		+-nlWorld J Gastroenterol 13(46):6156-65 (2007)
    472006Parathyroid hormone for the treatment of osteoporosis: a systematic review.



    		+-nlCMAJ 175(1):52-9 (2006) Cranney A
    482006Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.



    		+-nlCMAJ 175(1):48 (2006)
    492010Physiology of bone loss.



    		+-nlRadiol Clin North Am 48(3):483-95 (2010)
    502010High-resolution imaging techniques for the assessment of osteoporosis.



    		+-nlRadiol Clin North Am 48(3):601-21 (2010)
    512007The genetics of osteoporosis.



    		+-nlActa Reumatol Port 32(3):231-40 (2007)
    522007Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.



    		+-nlAltern Med Rev 12(2):113-45 (2007)
    532010How to prevent glucocorticoid-induced osteoporosis.



    		+-nlCleve Clin J Med 77(8):529-36 (2010)
    542008Biochemical markers of bone turnover: useful but underused.



    		+-nlCleve Clin J Med 75(10):751-2 (2008) Licata AA
    552010Osteoporosis - new treatments and updates.



    		+-nlBull NYU Hosp Jt Dis 68(3):166-70 (2010)
    562008Treatment strategies for patients with low bone mass: the younger postmenopausal female.



    		+-nlBull NYU Hosp Jt Dis 66(3):240-3 (2008)
    572011Update on medications with adverse skeletal effects.



    		+-nlMayo Clin Proc 86(4):338-43; quiz 343 (2011)
    582004Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.



    		+-nlChest 125(5):1859-76 (2004)
    592007Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures.



    		+-nlPain Physician 10(4):583-90 (2007)
    602002Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence.



    		+-nlJ Clin Endocrinol Metab 87(9):4033-41 (2002)
    612010Long-term use of bisphosphonates in osteoporosis.



    		+-nlJ Clin Endocrinol Metab 95(4):1555-65 (2010)
    622010Approach to the patient with secondary osteoporosis.



    		+-nlEur J Endocrinol 162(6):1009-20 (2010)
    632011Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.



    		+-nlEur J Endocrinol 165(1):1-10 (2011)
    642010Genetics of osteoporosis.



    		+-nlEndocr Rev 31(5):629-62 (2010)
    652004Androgens and bone.



    		+-nlEndocr Rev 25(3):389-425 (2004)
    662007Myeloma bone disease and proteasome inhibition therapies.



    		+-nlBlood 110(4):1098-104 (2007)
    672009The role of Dickkopf-1 in bone development, homeostasis, and disease.



    		+-nlBlood 113(3):517-25 (2009)
    682008Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.



    		+-nlJ Pharmacol Sci 106(4):542-6 (2008)
    692008Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.



    		+-nlJ Pharmacol Sci 106(4):530-5 (2008)
    702010Bone fractures after menopause.



    		+-nlHum Reprod Update 16(6):761-73 (2010)
    712011Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.



    		+-nlPLoS One 6(10):e26267 (2011)
    722010Bone loss across the menopausal transition.



    		+-nlAnn N Y Acad Sci 1192(-):66-71 (2010)
    732010Bone turnover across the menopause transition : The role of gonadal inhibins.



    		+-nlAnn N Y Acad Sci 1192(-):153-60 (2010)
    742009Osteoporosis in patients with systemic lupus erythematosus.



    		+-nlIsr Med Assoc J 11(8):486-91 (2009)
    752003What is osteoporosis?



    		+-nlPostgrad Med J 79(929):133-8 (2003)
    762007The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.



    		+-nlPostgrad Med J 83(982):509-17 (2007)
    772011Early diagnosis of osteoporosis by means of orthopantomograms and oral x-rays: a systematic review.



    		+-nlMed Oral Patol Oral Cir Bucal 16(7):e905-13 (2011)
    782010Post-transplantation osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 54(2):143-9 (2010)
    792010Bariatric surgery and bone metabolism: a systematic review.



    		+-nlArq Bras Endocrinol Metabol 54(2):158-63 (2010)
    802010SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.



    		+-nlArq Bras Endocrinol Metabol 54(2):200-5 (2010)
    812010Bisphosphonates in the treatment of metabolic bone diseases.



    		+-nlArq Bras Endocrinol Metabol 54(2):206-12 (2010)
    822010The use of PTH in the treatment of osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 54(2):213-9 (2010)
    832007Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.



    		+-nlArq Bras Endocrinol Metabol 51(8):1404-12 (2007)
    842006Glucocorticoid-induced osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 50(4):793-801 (2006)
    852006Transplantation osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 50(4):783-92 (2006)
    862006Low bone mass in children and adolescents.



    		+-nlArq Bras Endocrinol Metabol 50(4):775-82 (2006)
    872006Osteoporosis in men.



    		+-nlArq Bras Endocrinol Metabol 50(4):764-74 (2006)
    882006Update on osteoporosis therapy.



    		+-nlArq Bras Endocrinol Metabol 50(4):755-63 (2006)
    892006Anabolic skeletal therapy for osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 50(4):745-54 (2006)
    902006Bisphosphonates.



    		+-nlArq Bras Endocrinol Metabol 50(4):735-44 (2006)
    912006Estrogen therapy for postmenopausal osteoporosis.



    		+-nlArq Bras Endocrinol Metabol 50(4):705-19 (2006)
    922006Redefining osteoporosis treatment: Who to treat and how long to treat.



    		+-nlArq Bras Endocrinol Metabol 50(4):694-704 (2006)
    932006Office practice of osteoporosis evaluation.



    		+-nlArq Bras Endocrinol Metabol 50(4):674-84 (2006)
    9420102010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.



    		+-nlCMAJ 182(17):1864-73 (2010)
    952011Management and Treatment of Osteoporosis in Patients Receiving Long-term Glucocorticoid Treatment: Current Status of Adherence to Clinical Guidelines and Related Factors.



    		+-nlIntern Med 50(22):2793-800 (2011)
    962005The prevention and treatment of osteoporosis: a review.



    		+-nlMedGenMed 7(2):73 (2005)
    972009Current status of research on osteoporosis in COPD: a systematic review.



    		+-nlEur Respir J 34(1):209-18 (2009)
    982002Treatment of osteoporotic fractures.



    		+-nlScand J Surg 91(2):140-6 (2002)
    992003Invited Review: Pathogenesis of osteoporosis.



    		+-nlJ Appl Physiol 95(5):2142-51 (2003)
    1002011Effects of glucocorticoids on growth and bone mineralization.



    		+-nlJ Pediatr (Rio J) 87(1):4-12 (2011)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.